The next generation personalized models to screen hidden layers of breast cancer tumorigenicity

Breast Cancer Research and Treatment
F AfzaliM Gardaneh

Abstract

Breast cancer (BC) is a challenging disease and major cause of death amongst women worldwide who die due to tumor relapse or sidelong diseases. BC main complexity comes from the heterogeneous nature of breast tumors that demands customized treatments in the form of personalized medicine. Spatiotemporally dynamic and heterogeneous nature of BC tumors is shaped by their clonal evolution and sub-clonal selections and shapes resistance to collective or group therapies that drives cancer recurrence and tumor metastasis. Personalized intervention promises to administer medications that selectively target each individual patient tumor and even further each colonized secondary tumor. Such personalized regimens will require creation of in vitro and in vivo models genuinely recapitulating characteristics of each tumor type as initiating platforms for two main purposes: to closely monitor the tumorigenic processes that shape tumor heterogeneity and evolution as the main driving forces behind tumor chemo-resistance and relapse, and subsequently to establish patient-specific preventive and therapeutic measures. While application of tumor modeling for personalized drug screening and design requires a separate review, here we discuss the pers...Continue Reading

References

Apr 5, 2007·Nature Protocols·Christopher L Morton, Peter J Houghton
Nov 3, 2007·The Journal of Clinical Investigation·Kornelia Polyak
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Peter J CampbellMichael R Stratton
Jul 10, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Ketao JinGuangliang Li
Oct 13, 2010·Annual Review of Pathology·Dong-Joo Cheon, Sandra Orsulic
Dec 3, 2010·The Journal of Pathology·Alessandro Bombonati, Dennis C Sgroi
Nov 26, 2011·Cancer Discovery·Caterina NardellaPier Paolo Pandolfi
Jan 18, 2012·Breast Cancer Research : BCR·Fabien ReyalElisabetta Marangoni
Apr 18, 2012·Nature Reviews. Clinical Oncology·John J TentlerS Gail Eckhardt
Sep 4, 2012·Breast Cancer Research and Treatment·Laura A PetrilloLaura J Esserman
Sep 8, 2012·Methods in Molecular Biology·Shengyu YangXin-Yun Huang
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Dec 1, 2012·Science Translational Medicine·Rebecca J LearyVictor E Velculescu
May 30, 2013·The Journal of Pathology·Pierre MartinezCharles Swanton
Oct 26, 2013·Cancer Letters·Prerna MalaneyVrushank Davé
Dec 4, 2013·Genes & Development·Abba MalinaJerry Pelletier
Jan 23, 2014·Breast Cancer Research : BCR·Maria T GrindeIngrid S Gribbestad
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis A Diaz, Alberto Bardelli
Feb 21, 2014·Science Translational Medicine·Chetan BettegowdaLuis A Diaz
Apr 25, 2014·Nature Communications·Peter S Choi, Matthew Meyerson
Oct 23, 2014·Nature·Francisco J Sánchez-RiveraTyler Jacks
Aug 28, 2015·Science Translational Medicine·Isaac Garcia-MurillasNicholas C Turner
Jan 30, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Jamal-HanjaniC Swanton
Feb 15, 2016·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Katsutoshi ShodaEigo Otsuji
Apr 14, 2016·Cancer Cell·Tali MazorJoseph F Costello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

Translational Cancer Research
Noor HasanDaniela M Dinulescu
Clinical Advances in Hematology & Oncology : H&O
Manuel Hidalgo
© 2022 Meta ULC. All rights reserved